Maarten E. Emmelot

Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial

Evelien Kneppers, Bronno van der Holt, Marie José Kersten et al. · Blood · 2011 · 193 citations · Full text

Medicine, Hematology, Oncology +16

Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4⁺CD25^– cells

Tineke Aarts‐Riemens, Maarten E. Emmelot, Leo F. Verdonck et al. · European Journal of Immunology · 2008 · 99 citations · Full text

Life Sciences, Immunology, Molecular Biology +14

Human Regulatory T Cells Control Xenogeneic Graft-versus-Host Disease Induced by Autologous T Cells in RAG2−/−γc−/− Immunodeficient Mice

Tuna Mutis, Rozemarijn S. van Rijn, Elles Simonetti et al. · Clinical Cancer Research · 2006 · 96 citations

Life Sciences, Cell Biology, Immunology +16

A bioluminescence imaging based in vivo model for preclinical testing of novel cellular immunotherapy strategies to improve the graft-versus-myeloma effect

Henk Rozemuller, Ellen van der Spek, Lijnie Bogers-Boer et al. · Haematologica · 2008 · 46 citations · Full text

Medicine, Immunology, Oncology +16

Altered Peptide Ligands Revisited: Vaccine Design through Chemically Modified HLA-A2–Restricted T Cell Epitopes

Rieuwert Hoppes, Rimke Oostvogels, Jolien J. Luimstra et al. · The Journal of Immunology · 2014 · 46 citations · Full text

Life Sciences, Immunology, Molecular Biology +17